SOX2 and central nervous system cancer: In order to test the tumor initiation ability and the migratory phenotype of U343-MG cells with knockdown of SOX2 in vivo we stereotactically transplanted 5 × 105 glioma cells 5 days after transduction of shSOX2 #2378- and shLuc-vectors, respectively.